Skip to main content
Abliva logo

Abliva — Investor Relations & Filings

Ticker · ABLI ISIN · SE0002575340 LEI · 5493005YV22OTMUHZ183 ST Manufacturing
Open in API
Filings indexed 594 across all filing types
Latest filing 2022-08-19 Interim / Quarterly Rep…
Country SE Sweden
Listing ST ABLI

About Abliva

https://abliva.com

Abliva is a biopharmaceutical company that discovers and develops medicines for the treatment of primary mitochondrial diseases. These are rare, congenital, and often severe genetic disorders that occur when the cell's energy converters, the mitochondria, are dysfunctional. The company's research and development is focused on creating novel therapies aimed at restoring mitochondrial function and addressing the significant unmet medical needs of patients. Abliva's primary goal is to deliver treatments that provide meaningful clinical benefits for individuals suffering from these debilitating conditions.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2022
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Report January – June 2022' and contains comprehensive financial data, including income statements, loss per share, and management commentary on business performance for the specified period. It is a substantive financial report rather than a mere announcement or certification, fitting the definition of an Interim/Quarterly Report. H1 2022
2022-08-19 English
Major Shareholding Notification 2022
Major Shareholding Notification Classification · 1% confidence The document explicitly details a 'major shareholding notification' concerning the quantity of shares and voting rights held by 'Hadean Ventures AS' in 'Abliva AB' before and after a transaction. It specifies the reason for the notification ('Other') and the resulting distribution of holdings, including the percentage change (22.43968%). This content directly aligns with the definition of a Major Shareholding Notification, which corresponds to the filing code MRQ (Major Shareholding Notification). The document is short and contains specific transactional data, not a full report or an announcement about a report.
2022-08-02 English
Amended number of shares and votes in Abliva AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document explicitly announces an 'Amended number of shares and votes' following a preferential rights issue, stating the total number of shares and votes has increased. This directly relates to a change in the company's capital structure or share count. This aligns perfectly with the definition for 'Share Issue/Capital Change' (SHA). Although it is a short announcement, the core content is the capital change itself, not just the announcement of a report, making SHA a better fit than RPA or RNS. The document details the new total share count (1,056,299,165) resulting from the rights issue.
2022-07-29 English
Ändring av antal aktier och röster i Abliva AB (publ)
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a short announcement in Swedish titled "Ändring av antal aktier och röster i Abliva AB (publ)" (Change in the number of shares and votes in Abliva AB (publ)). It explicitly states that the number of shares and votes has increased due to a rights issue ('förtrycksemission') and provides the new total count. This directly relates to changes in the company's capital structure and share count. The content strongly aligns with the definition of 'Share Issue/Capital Change' (SHA). Although it mentions a prior announcement (the rights issue itself), this document is the official notification of the resulting change in the total number of shares, making SHA the most precise fit over a general regulatory filing (RNS) or a report publication announcement (RPA), as it contains the core data about the capital change itself.
2022-07-29 Swedish
Last day of trading with BTA in Abliva
Share Issue/Capital Change Classification · 1% confidence The document is explicitly titled as a 'Press Release' dated July 13, 2022, from Abliva AB. The content discusses the final stages of a rights issue, specifically announcing the 'Last day of trading with BTA' (paid subscribed shares) as July 18, 2022, and the subsequent conversion date. This is a specific corporate action announcement related to capital structure changes following a fundraising event (rights issue). While it relates to capital, the primary focus is announcing a specific procedural step (BTA trading cessation) resulting from the financing. This type of specific, time-sensitive corporate update, especially when issued as a press release detailing procedural steps rather than the initial fundraising terms or the final capital change itself, often falls under general Regulatory Filings (RNS) or, if it relates closely to the financing, Capital/Financing Update (CAP). Given the context of a rights issue completion and the announcement of trading mechanics, CAP is highly relevant. However, since the document is a short press release announcing a procedural update related to a prior financing event, and it doesn't detail the terms of the financing itself, it fits well as a general regulatory announcement. Since 'CAP' covers fundraising/financing activities, and this is the final procedural step of a rights issue, CAP is the most specific fit over the general RNS fallback. The document length is short (3681 chars) and it is a formal announcement.
2022-07-13 English
Sista dag för handel med BTA i Abliva
Share Issue/Capital Change Classification · 1% confidence The document is a short announcement dated July 13, 2022, titled "Sista dag för handel med BTA i Abliva" (Last day for trading in BTA in Abliva). It details the final trading day for a Paid Subscription Share (BTA) following a rights issue, including key dates like the last trading day (July 18, 2022), record date (July 20, 2022), and conversion date (July 22, 2022). It also contains extensive disclaimers about distribution restrictions in various jurisdictions (USA, Australia, etc.). The document is very short (3579 characters) and explicitly mentions that it is a 'Pressmeddelande' (Press Release) and includes a link to an attached PDF. According to Rule 2, when a document is short and announces the publication of information or attaches a report, it should be classified as a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Since this announcement is specifically about the publication/finalization of a corporate action related to financing (the rights issue), and it is structured as a brief announcement linking to the full details, RPA is the most appropriate classification, as it announces the final steps of a capital event. It is not the comprehensive financial report (10-K or IR) itself.
2022-07-13 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.